Preprint · CC-BY
via OpenAlex
Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan
Juhi Kumar, Charalampos Rallis
bioRxiv (Cold Spring Harbor Laboratory) · 2024 · ▲ 1 citations
Abstract
The mechanistic Target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition), mTOR, is a conserved pro-ageing pathway with characterised inhibitors such as rapamycin, rapalogues and torins. Bi-steric third-generation inhibitors, such as rapalink-1 have been developed, however, their effects on organismal gene expression and lifespan have not been characterised. Here, we demonstrate that rapalink-1 affects fission yeast spatial and temporal growth and prolongs chronological lifespan with a distinct TORC1 selectivity profile. Endosome and vesicle-mediated transport and homeostasis processes related to autophagy(definition) and Pik3, the orthologue of human PI3K, render cells resistant to rapalink-1. Our study reveals mTOR-regulated genes with unknown roles in ageing including all fission yeast agmatinases, the enzymes that convert agmatine to putrescine and urea. Through genome-wide screens, we identify sensitive and resistant mutants to agmatine and putrescine. Genetic interactome assays for the agmatinase agm1 and further cell and molecular analyses, demonstrate that impairing the agmatinergic branch of arginine catabolism results in mTOR activity levels that are beneficial for growth but detrimental for chronological ageing. Our study reveals the anti-ageing action of agmatinases within a metabolic feedback circuit regulating mTOR activity levels and ageing and with possible implications to other systems, including human cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2024.07.20.604404
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Kumar, J., & Rallis, C. (2024). Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2024.07.20.604404
Vancouver
Kumar J, Rallis C. Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan. bioRxiv (Cold Spring Harbor Laboratory). 2024. doi:10.1101/2024.07.20.604404.
BibTeX
@unpublished{juhi2024Rapali,
title = {Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan},
author = {Juhi Kumar and Charalampos Rallis},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2024},
doi = {10.1101/2024.07.20.604404},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Communications Biology 2025
Open access · CC-BY
Rapalink-1 reveals TOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating TOR activity and lifespan in fission yeast
2026
Preprint
Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging
PLoS ONE 2026
Open access · CC-BY
Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging
PloS one 2026
Open access · OA
Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging.
Frontiers in Cell and Developmental Biology 2019
Open access · CC-BY
Pleiotropic Effects of mTOR and Autophagy During Development and Aging
bioRxiv (Cold Spring Harbor Laboratory) 2026
Preprint · CC-BY